| Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Ormanns, S.; Haas, M.; Modest, D. P.; Kirchner, T.; Heinemann, V. (2013): KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer. In: Journal of Gastroenterology, Vol. 48, No. 4: pp. 544-548 |
Full text not available from 'Open Access LMU'.
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Institute for Medical Information Processing, Biometry and Epidemiology |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 1435-5922 |
| Language: | English |
| ID Code: | 33056 |
| Deposited On: | 15. Feb 2017 14:43 |
| Last Modified: | 04. Nov 2020 13:10 |
Repository Staff Only: item control page
